大麻治疗慢性疼痛:丹麦全国性研究中的心血管安全性
Anders Holt1,2, Nina Nouhravesh1, Jarl E Strange1,3
1Department of Cardiology, Copenhagen University Hospital-Herlev and Gentofte, Gentofte Hospitalsvej 6, PO Box 635, DK-2900 Hellerup, Denmark.
European heart journal
|January 11, 2024
概括
处方治疗慢性疼痛的医用大麻会增加心律失常的风险,尤其是在治疗开始后的180天内. 这项研究突出了使用医用大麻的患者潜在的心血管问题.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 疼痛管理 疼痛管理
背景情况:
- 医用大麻越来越多地用于治疗慢性疼痛.
- 娱乐性大麻使用与心血管问题有关.
- 治疗疼痛的医用大麻的安全性需要调查.
研究的目的:
- 在慢性疼痛患者中调查处方医用大麻的心血管安全性.
- 评估与医用大麻使用相关的新发性心律失常和急性冠状动脉综合征的风险.
主要方法:
- 全国范围的丹麦注册表用于识别开始使用医用大麻的慢性疼痛患者 (2018-21).
- 根据年龄,性别,诊断和药物治疗,患者与对照人群进行1:5匹配.
- 对比了心律失常和急性冠状动脉综合征的绝对风险.
主要成果:
- 医用大麻使用与新发性心律失常的风险增加有关 (180天风险比:2.07).
- 心律失常的风险在治疗开始后180天内最为明显.
- 医学大麻和急性冠状动脉综合征之间没有发现显著的关联.
结论:
- 处方医用大麻使用与慢性疼痛患者新发性心律失常的风险增加有关.
- 在治疗开始后的最初180天内,心律不整的风险增加最为显著.
- 对于使用医用大麻的患者,需要进一步进行心血管安全监测.
相关概念视频
Analgesia and Pain Management
625
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
625
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
279
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
279
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
197
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
197


